Grohmann, Gary

Dr Gary Grohmann

Virologist; Consultant, World Health Organisation; Board Member, Immunisation Coalition; Former Director, Immunobiology at the TGA; Adjunct Professor, Faculty of Medicine, University of Sydney
Dr. Gary Grohmann B. Sc. (Hons), PhD, FASM Gary Grohmann is former Director of Immunobiology and WHO ERL at the TGA, Office of Laboratories and Scientific services from 1997-2015. He currently works as an independent consultant, primarily with the WHO on influenza related projects in the Global Influenza Programme and the Essential Medicines Programme.

Dr. Grohmann has served on several WHO steering committees including the committee for the review of the IVTM database on influenza viruses and reassortant influenza viruses, and the WHO VCM committee that recommends virus strains for influenza vaccines (until 2015). He has also been a member of the Technical Advisory Group (2007-2015) of the Global Action Plan for Influenza.

His primary interests are in vaccines, vaccine regulation, medical and veterinary virology, and infectious diseases resulting from contaminated food and water as well as other environmental sources. Dr. Grohmann is currently a Board Member of the Immunisation Coalition and Adjunct Professor at the University of Sydney.

More from this expert

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

Podcasts iconPodcasts

Listen to the latest on Long COVID, with Dr Gary Grohmann, where we address the important considerations for Long COVID, what we know now, and how to treat, prevent and reduce the severity of Long COVID.

Podcasts iconPodcasts

Upcoming Healthed Webcast

Tune in for "Gallbladder – When surgery is or is not needed" lecture

Tuesday 26th May, 7pm - 9pm AEST

Speaker

Dr David Yeo

Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals

In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.